Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Antisense oligonucleotide targeting ARL4C molecule, and nucleic acid drug using antisense oligonucleotide

Antisense oligonucleotide targeting ARL4C molecule, and nucleic acid drug using antisense oligonucleotide

US Patent 12071624 · Granted Aug 27, 2024

Estimated economic value: $340,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Cross-linked nucleoside and nucleotide using same2025
5′-modified nucleoside and nucleotide using same2025
Chimeric double-stranded nucleic acid2025
Crosslinked artificial nucleic acid ALNA2025
Antisense oligonucleic acid2024
Antisense oligonucleic acid2024
Nucleic acid compound and oligonucleotide2024
Small cell lung cancer therapeutic agent containing oligonucleotide2024
Small cell lung cancer therapeutic agent containing oligonucleotide2024
Anti-CKAP4 monoclonal antibody2023
Oblique inflation type balloon catheter and balloon base2023
Antisense nucleic acid for inhibiting biosynthesis of chondroitin sulfate2022